Fig. 6
From: Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation
Safety coagulation tests for FEAM treatment: FEAM was found to not affect coagulation profile, including anti- Xa levels (A), activated protein C resistance (APCR) (B), activated partial thromboplastin time (APTT) (C), prothrombin time (PT) (D), and thrombin time (TT) (E). N = 5–6. Results are presented as mean ± SEM